Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Former Medtronic and Zimmer-Biomet VP joins back pain startup as CEO

October 1, 2021 By Jim Hammerand

Jeff Cambra, CEO of SpinaFX

Jeff Cambra, CEO of SpinaFX [Photo courtesy of SpinaFX]

Jeff Cambra is the new CEO of SpinaFX Medical, the back pain therapy startup said on Friday.

Cambra was previously a vice president at Zimmer Biomet (NYSE:ZBH), “leading product management for their $5 billion global reconstruction business,” SpinaFX said in a news release. He served in that role from November 2020 to June 2021, according to his LinkedIn page.

He ended a nearly 11-year career at Medtronic (NYSE:MDT) in 2020, ultimately serving as vice president and general manager of interventional therapies. SpinaFX said he “led a successful turnaround of their $400 million vertebral augmentation and oncology business through new technology innovation, strategic partnerships, acquisitions and expanding margins.”

“With my passion for the interventional space, I constantly assess and monitor multiple promising technologies, I recognized the breakthrough potential of SpinaFX’s technology over a decade ago,” Camber said in the news release. “SpinaFX is an excellent opportunity to leverage my experience in the medical device field to deliver value for our patients, our customers and our shareholders.”  

SpinaFX is headquartered near Toronto, Canada. The company said it has developed a minimally invasive, image-guided treatment for back pain from herniated discs, injecting a controlled oxygen formulation to reduce herniation and inflammation.

SpinaFX said its Triojection product was previously CE marked under the European Union’s Medical Device Directive and is undergoing recertification under the new Medical Device Regulation. Triojection is not yet approved for sale in North America, the U.K. or the EU.

“Jeff is a highly regarded leader in the medical device industry, with a proven track record of building great businesses and creating shareholder value,” SpinaFx Executive Chairman Igor Keselman said in the news release. “We’re confident that Jeff’s vision, operational discipline and commercial acumen make him the ideal leader for SpinaFX, and we’re excited to leverage his experience to help us reach the next level.”

You may also like:

  • Medtronic Hugo robot-assisted surgery system
    Medtronic’s Hugo team ‘waiting for the phone call’ for approval…

Related Articles Read More >

iRhythm stays silent on federal grand jury subpoenas
Samsung workers in clean room gear walking down a corridor at a semiconductor fabrication plant
Texas power grid struggles in heat one year after record cold stopped semiconductor plants
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
Product packaging for the Lucira combination COVID-19 and flu test
Lucira Health asks FDA for EUA on molecular at-home COVID/flu test

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech